Manufacturing with pluripotent stem cells ( PSConf 2021): Key issues for future research and development

Translating stem cell research into development of cellular drugs—a perspective from manufacture of stem cell products and CMC considerations

(2022) Yu Alex Zhang et al.   CELL PROLIFERATION

Development and regulation of stem cell‐based therapies in China

(2022) Jianchao Gao et al.   CELL PROLIFERATION

Knowledge graphs of ethical concerns of cerebral organoids

(2022) Lulu Ding et al.   CELL PROLIFERATION

Scalable manufacturing of clinical‐grade differentiated cardiomyocytes derived from human‐induced pluripotent stem cells for regenerative therapy

(2022) Yuika Morita et al.   CELL PROLIFERATION

Advances in hPSC expansion towards therapeutic entities: A review

(2022) Shelly E. Tannenbaum et al.   CELL PROLIFERATION

Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactors

(2021) Amanda L. Evans et al.   Blood Advances

ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update

(2021) Robin Lovell-Badge et al.   Stem Cell Reports

A Manually Curated Database on Clinical Studies Involving Cell Products Derived from Human Pluripotent Stem Cells

(2020) Sabine Kobold et al.   Stem Cell Reports

Pluripotent Stem Cell-Based Cell Therapy—Promise and Challenges

(2020) Shinya Yamanaka   Cell Stem Cell

Fatty Acid Synthesis Is Indispensable for Survival of Human Pluripotent Stem Cells

(2020) Sho Tanosaki et al.   iScience

A pathway for attesting ethical provenance of cell lines: Lessons from the European human pluripotent stem cell registry (hPSCreg)

(2019) Rosario Isasi et al.   Stem Cell Research

Development of a transplant injection device for optimal distribution and retention of human iPSC-derived cardiomyocytes

(2018) Ryota Tabei et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells

(2017) Jung-Hyun Kim et al.   Stem Cells Translational Medicine

Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes

(2017) Shugo Tohyama et al.   Stem Cell Reports

Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells

(2016) Shugo Tohyama et al.   Cell Metabolism

Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)

(2015) PW Andrews et al.   Regenerative Medicine

Identifiability and Privacy in Pluripotent Stem Cell Research

(2014) Rosario Isasi et al.   Cell Stem Cell

Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes

(2012) Shugo Tohyama et al.   Cell Stem Cell

Derivation of Xeno-Free and GMP-Grade Human Embryonic Stem Cells – Platforms for Future Clinical Applications

(2012) Shelly E. Tannenbaum et al.   PLoS One

Disclosure and management of research findings in stem cell research and banking: policy statement

(2012) Rosario Isasi et al.   Regenerative Medicine

Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension

(2010) Debora Steiner et al.   NATURE BIOTECHNOLOGY